title: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
authors.forename: Stephen F
authors.initials: SF
authors.lastname: Hodgson
authors.forename: Nelson B
authors.initials: NB
authors.lastname: Watts
authors.forename: John P
authors.initials: JP
authors.lastname: Bilezikian
authors.forename: Bart L
authors.initials: BL
authors.lastname: Clarke
authors.forename: T Kenney
authors.initials: TK
authors.lastname: Gray
authors.forename: David W
authors.initials: DW
authors.lastname: Harris
authors.forename: C Conrad
authors.initials: CC
authors.lastname: Johnston
authors.forename: Michael
authors.initials: M
authors.lastname: Kleerekoper
authors.forename: Robert
authors.initials: R
authors.lastname: Lindsay
authors.forename: Marjorie M
authors.initials: MM
authors.lastname: Luckey
authors.forename: Michael R
authors.initials: MR
authors.lastname: McClung
authors.forename: Howard R
authors.initials: HR
authors.lastname: Nankin
authors.forename: Steven M
authors.initials: SM
authors.lastname: Petak
authors.forename: Robert R
authors.initials: RR
authors.lastname: Recker
mesh_terms: D000058:Accidental Falls / Q000517:prevention & control; D000368:Aged; D015519:Bone Density; D001846:Bone Development; D016723:Bone Remodeling; D001842:Bone and Bones / Q000293:injuries; D002116:Calcitonin / Q000008:administration & dosage / Q000009:adverse effects; D002136:Calcium, Dietary / Q000008:administration & dosage; D000075202:Contraindications; D019587:Dietary Supplements; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects; D004704:Endocrinology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D015444:Exercise; D005260:Female; D050723:Fractures, Bone / Q000175:diagnosis / Q000209:etiology; D006620:Hip Fractures / Q000209:etiology; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control* / Q000628:therapy*; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage / Q000009:adverse effects; D019379:Teriparatide / Q000008:administration & dosage / Q000009:adverse effects; D014807:Vitamin D / Q000008:administration & dosage
chemical_list: D002136:Calcium, Dietary; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D019379:Teriparatide; D014807:Vitamin D; D002116:Calcitonin